Home
/
Exousia Bio, Inc.
/
Financials
/
Quarterly
Exousia Bio, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Exousia Bio, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Nov 30, 2025
$0
Mar 17, 2026
Q1
2026
Aug 31, 2025
$0
Nov 17, 2025
Q3
2025
Feb 28, 2025
$0
Apr 24, 2025
Q2
2026
Nov 30, 2024
$0
Mar 17, 2026
Q1
2026
Aug 31, 2024
$3.8K
Nov 17, 2025
Q3
2025
Feb 29, 2024
$3.9K
Apr 24, 2025
Q2
2025
Nov 30, 2023
$3.9K
Jan 10, 2025
Q1
2025
Aug 31, 2023
$0
Oct 11, 2024
Q3
2024
Feb 28, 2023
$0
Apr 15, 2024
Q2
2024
Nov 30, 2022
$0
Jan 16, 2024
Q1
2024
Aug 31, 2022
$0
Oct 11, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Nov 30, 2025
($19.1K)
Mar 17, 2026
Q1
2026
Aug 31, 2025
($31.8K)
Nov 17, 2025
Q3
2025
Feb 28, 2025
$61.8K
Apr 24, 2025
Q2
2026
Nov 30, 2024
$80.1K
Mar 17, 2026
Q1
2026
Aug 31, 2024
($3.9K)
Nov 17, 2025
Q3
2025
Feb 29, 2024
($4.8K)
Apr 24, 2025
Q2
2025
Nov 30, 2023
($3.6K)
Jan 10, 2025
Q1
2025
Aug 31, 2023
($12.2K)
Oct 11, 2024
Q3
2024
Feb 28, 2023
($8.3K)
Apr 15, 2024
Q2
2024
Nov 30, 2022
($8.4K)
Jan 16, 2024
Q1
2024
Aug 31, 2022
($13.0K)
Oct 11, 2023
Q3
2023
May 31, 2022
($937)
May 8, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2026
Nov 30, 2025
($237.0K)
Mar 17, 2026
Q1
2026
Aug 31, 2025
($31.8K)
Nov 17, 2025
Q2
2026
Nov 30, 2024
$7.0K
Mar 17, 2026
Q1
2026
Aug 31, 2024
($4.3K)
Nov 17, 2025
Q3
2024
Feb 29, 2024
($8.7K)
Apr 15, 2024
Q2
2024
Nov 30, 2023
($7.4K)
Jan 16, 2024
Q1
2024
Aug 31, 2023
($12.2K)
Oct 11, 2023
Q3
2024
Feb 28, 2023
($8.3K)
Apr 15, 2024
Q2
2024
Nov 30, 2022
($8.4K)
Jan 16, 2024
Q1
2024
Aug 31, 2022
($13.0K)
Oct 11, 2023